Home / Intelligence / Case Studies / Global Value Messaging and P&MA Strategy for a CAR T Cell Therapy
Trinity completed an engagement to support the successful launch of a CAR T cell therapy with distinct clinical profile in a competitive landscape.
The client asked Trinity to develop and externally validate global payer value messages and the associated evidence set for their CAR T cell therapy. They also required support with developing a robust global pricing and market access strategy for their asset.
Trinity conducted focus groups and In-Depth-Interviews (IDIs) with key payer and provider stakeholders in scope markets to understand the evolving cell therapy landscape and identify unique opportunities and challenges that are relevant for “one-time” therapies.
- Outputs from internal workshops summarizing alignment among cross-functional stakeholders
- Refined value story and supporting exhibits for the CAR T cell therapy
- Key learnings and actionable recommendations informing pricing and market access strategy
Project Outcomes & Impact
The client was provided with an impactful value, access, and pricing strategy for a CAR T cell therapy product to successfully convey differentiation in an increasingly crowded and competitive environment.
Sign up for the latest intelligence